Biological Imaging Reagents Market: Nuclear Imaging Gaining Traction, Globally

The use of nuclear medicine for research and disease treatment dates back to the first half of the 20th century, when they began to be used as tracer elements. Subsequent developments in nuclear medicine and molecular imaging have led to a variety of radiopharmaceutical substances being used for the diagnosis of different diseases. Nuclear imaging modalities such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT), which use these radiopharmaceuticals, are now being offered as a routine option in the diagnosis and treatment of diseases. With benefits such as better quality of images and precision in the detection of illnesses made possible, particularly in the early detection and diagnosis of cancers, nuclear imaging as a modality within the biological imaging reagents market has been gaining traction in recent years. This modality in the global biological imaging reagents market was valued at ~US$ 2.3 Bn in 2018 and is expected to expand the most among all, at a CAGR of ~9% during the forecast years.

biological imaging reagents market infographic

To know the scope of our report Get a Sample on Biological Imaging Reagents Market 

Popularity of Multimodal Imaging to Propel Growth of Biological Imaging Reagents Market

The obvious advantages of multimodal imaging, or multiplexed imaging, over single modality imaging, such as better visualization and more precise images, have contributed significantly to their popularity. The introduction and incorporation of newer technologies and tools, particularly that use multiple imaging techniques, have gained purchase in the larger imaging landscape. For instance, the increased use of PET-SPECT hybrid and PET-MRI imaging systems globally, due to their many benefits, has contributed significantly to the expansion of the biological imaging reagents market.

Manufacturers in the global biological imaging reagents market, focusing on these multimodal techniques, are likely to witness increased potential in the field of research and drug discovery. 

Incorporating Technology in Molecular Imaging to Positively Impact Market

The larger imaging landscape has not been immune to the pervasive influence of technology, which has not just caused the industry to progress by leaps and bounds with the development of multimodal imaging techniques, but has also resulted in better prospects for standardized imaging. For instance, the incorporation of AI into molecular imaging is becoming increasingly popular, as the potential for AI to improve diagnostic accuracy is vast, and is only beginning to be explored. With these advancements being incorporated into existing imaging technologies, it has had a significant positive impact on the growth of the biological imaging reagents market. 

Developing Regions to Offer Opportunities Due to Increasing Incidence of Illnesses

In 2018, the developed markets of North America and Europe accounted for over two-thirds of the total share in the global biological imaging reagents market, by revenue. This is likely to continue throughout the forecast period, with both, short- and long-term predictions for these regions remaining the same. This can be attributed to the sheer number of tests being performed in these regions, coupled with increased awareness and concern for early stage disease detection.

Get a glimpse of the in-depth analysis through our Report Brochure

However, there has been the rising incidence of chronic diseases and illnesses in developing regions such as APAC and Latin America, pushing for the rapid growth of these regional markets. Expected to register value CAGRs of ~9% in both regions, these two markets are likely to expand to twice their size by the end of the forecast period. This can also be credited to the improvement of healthcare infrastructure in these regions, and players’ increased focus on research & development activities. Manufacturers in the biological imaging reagents market are looking to make inroads into these regions to expand their geographical reach and strengthen their global standing in the process. 

Biological Imaging Reagents Market: Competition Analysis

The global biological imaging reagents market is considered to be moderately consolidated, with tier-1 players occupying a larger share of the landscape. These players are increasingly focusing on mergers and acquisitions to consolidate their position in this highly competitive landscape. For instance, in April 2019, PerkinElmer, Inc., a major player in the market, acquired Cisbio Bioassays – a leading life science company.

Players are also increasingly focusing on new product development as a strategy to widen their global footprint. An example of this strategy is, in August 2019, Bracco S.p.A. received FDA approval for -Varibar ® Thin Liquid (barium sulfate) for oral suspension, for the detection and assessment of the type and severity of swallowing disorders.

biological imaging reagents market segmentation
Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Overview of Biological Imaging Reagents Market

The global biological imaging reagents market is set to grow at a robust pace during the forecast period, due to the high prevalence of chronic illnesses, globally, and the consequent rise in diagnostic procedures for their detection. According to analysts at Transparency Market Research, players in this market should focus on products that can be employed in multimodal imaging for maximum gains in the near future. Manufacturers in the biological imaging reagents market are focusing on R&D and partnerships with academic institutes to maximize their gains during the forecast period.

Regional markets in APAC and LATAM in the global biological imaging reagents landscape are expected to grow the fastest during the forecast period. These regions offer lucrative prospects for manufacturers to make inroads to strengthen their regional and local presence.

With technology moving at such a rapid pace, and the demand for better and more precise images taking precedence, the future is set to be rewarding for manufacturers of biological imaging reagents, looking to leverage technological advances into imaging solutions and their manufacturing process.

Biological Imaging Reagents Market: Description

  • Biological imaging reagents are substances and agents used in different imaging modalities, such as X-ray, magnetic resonance imaging, and ultrasound, for better visualization of internal body organs for the diagnosis of various diseases.
  • These agents are used for assistance in the detection of biological processes at the molecular level in order to conduct diagnosis and research.
  • These imaging and detection technologies are extensively used in pharmaceutical, biotechnology, and medical industries for research and diagnosis.
  • Biological imaging reagents are applied in these fields as contrast, optical, and nuclear reagents. Some multimodal imaging technologies are also gaining popularity as better visualization tools and imaging reagents. 

Biological Imaging Reagents Market: Overview

  • The global biological imaging reagents market was valued at ~US$ 13.5 Bn in 2018 and is projected to expand at a CAGR of 8.5%, to reach ~US$ 28 Bn by 2027.
  • Growth of the global biological imaging reagents market can be ascribed to the rise in the prevalence of diseases that need diagnostic imaging tests. Hence, increase in the number of imaging procedures for diagnosis & research has led to the growth of the global biological imaging reagents market.
  • Advancement in technologies such as nanotechnology and microfluidics are some of the evolving trends in the industry.
  • Research companies are targeting contrast reagents, as these are applicable in a large number of modalities. 

Global Biological Imaging Reagents Market Drivers

  • The high prevalence and increase in the incidence rate of different chronic diseases such as cardiovascular diseases, different forms of cancer, diabetes, and neurological disorders across the globe have been observed in recent times.
  • This higher prevalence of diseases has put more pressure on new technologies for diagnosis.
  • The diseases mentioned above are better diagnosed by different imaging modalities. Increase in the number of diagnostic imaging procedures also boosts the growth of the global biological imaging reagents market.
  • Moreover, surge in research activities for drug discovery and new product launches in the past few years for specific indications are other factors fueling the growth of the global biological imaging reagents market. 

Biological Imaging Reagents Market: Key Segments

  • Precise imaging and rise in demand for radiopharmaceutical agents in cardiac procedures propel the nuclear reagents segment in the global biological imaging reagents market.
  • Ultrasound microbubbles is a new trend that shows promising growth due to recently approved products for specific indications.
  • Rise in the demand for contrast reagents in different modalities and recently launched products in this category are major factors driving the contrast reagents segment in the global biological imaging reagents market.
  • Based on modality, nuclear is anticipated to be a highly lucrative segment in the global biological imaging reagents market, owing to the higher adoption rate of PET & SPECT modalities.
  • In terms of application, the in-vivo segment dominated the market, owing to the higher consumption of imaging reagents in live cell in-vivo imaging, and increase in research activities.
  • Based on end user, the life science companies segment is expected to be a highly lucrative segment in the global biological imaging reagents market during the forecast period, owing to major collaborations and partnerships of biopharmaceutical companies with CROs. 

Global Biological Imaging Reagents Market: Major Players

  • Key players analyzed in the report on the global biological imaging reagents market are
    • Bayer AG
    • Thermo Fisher Scientific, Inc.
    • PerkinElmer, Inc.
    • Guerbet
    • Lantheus Holdings, Inc.
    • Bracco S.p.A.
    • GE Healthcare
    • Becton
    • Dickinson and Company (BD)
    • Siemens Healthineers
    • Luminex Corporation
  • Each of these players has been profiled in the report on the global biological imaging reagents market, based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
  • In April 2017, Lantheus Holdings, Inc. entered into a definitive, exclusive collaboration and license agreement with GE Healthcare for the continued phase 3 development and worldwide commercialization of flurpiridaz F 18.
  • In December 2017, Siemens Healthineers acquired FAST TRACK DIAGNOSTICS LUXEMBOURG S.à r.l. (formerly FTD Investments S.à r.l.). This acquisition strengthened the company’s growth in molecular diagnostics.
  • Strategic mergers & acquisitions, new product launches, and emphasis on research & development are the key strategies adopted by major players in the global biological imaging reagents market.
  • In July 2019, Bayer AG received FDA approval for Gadavist (gadobutrol) injection in the U.S., for use in cardiac magnetic resonance (MR) imaging to assess myocardial perfusion (stress, rest).

Global Biological Imaging Reagents Market - Segmentation

TMR’s study on the global biological imaging reagents market includes information divided into five sections: class, modality, application, end user, and region. Changing industry trends and other crucial market dynamics associated with these sections of the global biological imaging reagents market have been discussed in detail.

Class

Contrast Reagents

Optical Reagents

Nuclear Reagents

Modality

MRI

Ultrasound

X-ray & CT

Nuclear

  • PET
  • SPECT

Optical Imaging

Others

Application

In Vitro

  • Proteomics
  • Genomics
  • Cell Biology

In Vivo

End User

Diagnostic Laboratories

Life Science Companies

Imaging Centers

Academic & Research Institutes

Others

Region

North America

Europe

Asia Pacific

Latin America

MEA

Frequently Asked Questions

Biological imaging reagents market to reach a valuation of ~US$ 28 Bn by 2027

Biological imaging reagents market is expected to expand at a CAGR of ~9% during 2019 - 2027

Biological imaging reagents market is driven by increase in the number of diagnostic imaging procedures

North America dominated the global biological imaging reagents market, and the trend is projected to continue during the forecast period

Key players in the global biological imaging reagents market include Bayer AG, Thermo Fisher Scientific, Inc., PerkinElmer, Inc. Guerbet, Lantheus Holdings, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biological Imaging Reagents Market

4. Market Overview

    4.1. Introduction

        4.1.1. Class Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Regulatory Scenario by Region/globally

    5.2. Technological Advancements

    5.3. Disease Prevalence & Incidence Rate globally with key countries

6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class, 2017–2027 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Class, 2017–2027

        6.3.1. Contrast Reagents

        6.3.2. Optical Reagents

        6.3.3. Nuclear Reagents

    6.4. Market Attractiveness, by Class 

7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality, 2017–2027 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Modality, 2017–2027

        7.3.1. MRI

        7.3.2. Ultrasound

        7.3.3. X-ray & CT

        7.3.4. Nuclear

            7.3.4.1. PET

            7.3.4.2. SPECT

        7.3.5. Optical Imaging

        7.3.6. Others

    7.4. Market Attractiveness, by Modality 

8. Global Biological Imaging Reagents Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Application, 2017–2027

        8.3.1. In Vitro

            8.3.1.1. Proteomics

            8.3.1.2. Genomics

            8.3.1.3. Cell Biology

        8.3.2. In Vivo

    8.4. Market Attractiveness, by Application

9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user, 2017–2027 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2017–2027

        9.3.1. Diagnostic Laboratories

        9.3.2. Imaging Centers

        9.3.3. Life Sciences Companies

        9.3.4. Academic & Research Institutes

        9.3.5. Others

    9.4. Market Attractiveness, by End-user 

10. Global Biological Imaging Reagents Market Analysis and Forecasts, by Region, 2017–2027

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America 

        10.2.2. Europe 

        10.2.3. Asia Pacific 

        10.2.4. Latin America 

        10.2.5. Middle East & Africa 

    10.3. Market Attractiveness, by Country/Region

11. North America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    11.1.Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Class, 2017–2027

        11.2.1. Contrast Reagents

        11.2.2. Optical Reagents

        11.2.3. Nuclear Reagents

    11.3. Market Value Forecast, by Modality, 2017–2027

        11.3.1. MRI

        11.3.2. Ultrasound

        11.3.3. X-ray & CT

        11.3.4. Nuclear

            11.3.4.1. PET

            11.3.4.2. SPECT

        11.3.5. Optical Imaging

        11.3.6. Others

    11.4. Market Value Forecast, by Application, 2017–2027

        11.4.1. In Vitro

            11.4.1.1. Proteomics

            11.4.1.2. Genomics

            11.4.1.3. Cell Biology

        11.4.2. In Vivo

    11.5. Market Value Forecast, by End-user, 2017–2027

        11.5.1. Diagnostic Laboratories

        11.5.2. Imaging Centers

        11.5.3. Life Sciences Companies

        11.5.4. Academic & Research Institutes

        11.5.5. Others

    11.6. Market Value Forecast, by Country, 2017–2027

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis 

        11.7.1. By Class 

        11.7.2. By Modality 

        11.7.3. By Application

        11.7.4. By End-user 

        11.7.5. By Country

12. Europe Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Class, 2017–2027

        12.2.1. Contrast Reagents

        12.2.2. Optical Reagents

        12.2.3. Nuclear Reagents

    12.3. Market Value Forecast, by Modality, 2017–2027

        12.3.1. MRI

        12.3.2. Ultrasound

        12.3.3. X-ray & CT

        12.3.4. Nuclear

            12.3.4.1. PET

            12.3.4.2. SPECT

        12.3.5. Optical Imaging

        12.3.6. Others

    12.4. Market Value Forecast, by Application, 2017–2027

        12.4.1. In Vitro

            12.4.1.1. Proteomics

            12.4.1.2. Genomics

            12.4.1.3. Cell Biology

        12.4.2. In Vivo

    12.5. Market Value Forecast, by End-user, 2017–2027

        12.5.1. Diagnostic Laboratories

        12.5.2. Imaging Centers

        12.5.3. Life Sciences Companies

        12.5.4. Academic & Research Institutes

        12.5.5. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis 

        12.7.1. By Class 

        12.7.2. By Modality 

        12.7.3. By Application

        12.7.4. By End-user 

        12.7.5. By Country/Sub-region

13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Class, 2017–2027

        13.2.1. Contrast Reagents

        13.2.2. Optical Reagents

        13.2.3. Nuclear Reagents

    13.3. Market Value Forecast, by Modality, 2017–2027

        13.3.1. MRI

        13.3.2. Ultrasound

        13.3.3. X-ray & CT

        13.3.4. Nuclear

            13.3.4.1. PET

            13.3.4.2. SPECT

        13.3.5. Optical Imaging

        13.3.6. Others

    13.4. Market Value Forecast, by Application, 2017–2027

        13.4.1. In Vitro

            13.4.1.1. Proteomics

            13.4.1.2. Genomics

            13.4.1.3. Cell Biology

        13.4.2. In Vivo

    13.5. Market Value Forecast, by End-user, 2017–2027

        13.5.1. Diagnostic Laboratories

        13.5.2. Imaging Centers

        13.5.3. Life Sciences Companies

        13.5.4. Academic & Research Institutes

        13.5.5. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis 

        13.7.1. By Class 

        13.7.2. By Modality 

        13.7.3. By Application

        13.7.4. By End-user 

        13.7.5. By Country/Sub-region

14. Latin America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Class, 2017–2027

        14.2.1. Contrast Reagents

        14.2.2. Optical Reagents

        14.2.3. Nuclear Reagents

    14.3. Market Value Forecast, by Modality, 2017–2027

        14.3.1. MRI

        14.3.2. Ultrasound

        14.3.3. X-ray & CT

        14.3.4. Nuclear

            14.3.4.1. PET

            14.3.4.2. SPECT

        14.3.5. Optical Imaging

        14.3.6. Others

    14.4. Market Value Forecast, by Application, 2017–2027

        14.4.1. In Vitro

            14.4.1.1. Proteomics

            14.4.1.2. Genomics

            14.4.1.3. Cell Biology

        14.4.2. In Vivo

    14.5. Market Value Forecast, by End-user, 2017–2027

        14.5.1. Diagnostic Laboratories

        14.5.2. Imaging Centers

        14.5.3. Life Sciences Companies

        14.5.4. Academic & Research Institutes

        14.5.5. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis 

        14.7.1. By Class 

        14.7.2. By Modality 

        14.7.3. By Application

        14.7.4. By End-user 

        14.7.5. By Country/Sub-region

15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Class, 2017–2027

        15.2.1. Contrast Reagents

        15.2.2. Optical Reagents

        15.2.3. Nuclear Reagents

    15.3. Market Value Forecast, by Modality, 2017–2027

        15.3.1. MRI

        15.3.2. Ultrasound

        15.3.3. X-ray & CT

        15.3.4. Nuclear

            15.3.4.1. PET

            15.3.4.2. SPECT

        15.3.5. Optical Imaging

        15.3.6. Others

    15.4. Market Value Forecast, by Application, 2017–2027

        15.4.1. In Vitro

            15.4.1.1. Proteomics

            15.4.1.2. Genomics

            15.4.1.3. Cell Biology

        15.4.2. In Vivo

    15.5. Market Value Forecast, by End-user, 2017–2027

        15.5.1. Diagnostic Laboratories

        15.5.2. Imaging Centers

        15.5.3. Life Sciences Companies

        15.5.4. Academic & Research Institutes

        15.5.5. Others

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2027

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis 

        15.7.1. By Class 

        15.7.2. By Modality 

        15.7.3. By Application 

        15.7.4. By End-user 

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (By Tier and Size of companies)

    16.2. Market Position/Ranking Analysis, by Company (2018)

    16.3. Company Profiles

        16.3.1. Bayer AG

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Company Financials

            16.3.1.3. Growth Strategies

            16.3.1.4. SWOT Analysis

        16.3.2. Thermo Fisher Scientific, Inc.

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Company Financials

            16.3.2.3. Growth Strategies

            16.3.2.4. SWOT Analysis

        16.3.3. PerkinElmer, Inc.

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Company Financials

            16.3.3.3. Growth Strategies

            16.3.3.4. SWOT Analysis

        16.3.4. Guerbet

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Company Financials

            16.3.4.3. Growth Strategies

            16.3.4.4. SWOT Analysis

        16.3.5. Lantheus Holdings, Inc.

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Company Financials

            16.3.5.3. Growth Strategies

            16.3.5.4. SWOT Analysis

        16.3.6. Bracco S.p.A.

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Company Financials

            16.3.6.3. Growth Strategies

            16.3.6.4. SWOT Analysis

        16.3.7. GE Healthcare

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Company Financials

            16.3.7.3. Growth Strategies

            16.3.7.4. SWOT Analysis

        16.3.8. Becton, Dickinson and Company (BD)

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Company Financials

            16.3.8.3. Growth Strategies

            16.3.8.4. SWOT Analysis

        16.3.9. Siemens Healthineers

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Company Financials

            16.3.9.3. Growth Strategies

            16.3.9.4. SWOT Analysis

        16.3.10. Luminex Corporation

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Company Financials

            16.3.10.3. Growth Strategies

            16.3.10.4. SWOT Analysis

List of Tables

Table 01: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 02: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 03: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 04: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 05: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 06: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 07: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 08: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 10: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 11: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 12: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 13: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 14: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 15: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 17: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 18: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 19: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 20: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 21: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 22: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 23: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 24: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 25: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 26: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 27: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 28: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 29: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 31: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 32: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 33: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 34: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 35: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 36: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 37: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 38: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 39: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 40: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 41: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 42: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global Biological Imaging Reagents Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Global Biological Imaging Reagents Market Value Share, by Class (2018)

Figure 04: Global Biological Imaging Reagents Market Value Share, by Modality (2018)

Figure 05: Global Biological Imaging Reagents Market Value Share, by Application (2018)

Figure 06: Global Biological Imaging Reagents Market Value Share, by End-user (2018)

Figure 07: Global Biological Imaging Reagents Market Value Share, by Region (2018)

Figure 08: Global Biological Imaging Reagents Market Value Share Analysis, by Class, 2018 and 2027

Figure 09: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contrast Reagents, 2017–2027

Figure 10: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Optical Reagents, 2017–2027

Figure 11: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nuclear Reagents, 2017–2027

Figure 12: Global Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 13: Global Biological Imaging Reagents Market Value Share Analysis, by Modality, 2018 and 2027

Figure 14: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by MRI, 2017–2027

Figure 15: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ultrasound, 2017–2027

Figure 16: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by X-ray & CT, 2017–2027

Figure 17: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nuclear, 2017–2027

Figure 18: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Optical Imaging, 2017–2027

Figure 19: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 20: Global Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 21: Global Biological Imaging Reagents Market Value Share Analysis, by Application, 2018 and 2027

Figure 22: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vitro, 2017–2027

Figure 23: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vivo, 2017–2027

Figure 24: Global Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 25: Global Biological Imaging Reagents Market Value Share Analysis, by End-user, 2018 and 2027

Figure 26: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027

Figure 27: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Imaging Centers, 2017–2027

Figure 28: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Life Sciences Companies, 2017–2027

Figure 29: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Research Institutes, 2017–2027

Figure 30: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 31: Global Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 32: Global Biological Imaging Reagents Market Value Share, by Region, 2018 and 2027

Figure 33: Global Biological Imaging Reagents Market Attractiveness, by Region, 2019–2027

Figure 34: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 35: North America Biological Imaging Reagents Market Value Share, by Country, 2018 and 2027

Figure 36: North America Biological Imaging Reagents Market Attractiveness, by Country, 2019–2027

Figure 37: North America Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 38: North America Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 39: North America Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 40: North America Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 41: North America Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 42: North America Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 43: North America Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 44: North America Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 45: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 46: Europe Biological Imaging Reagents Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 47: Europe Biological Imaging Reagents Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 48: Europe Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 49: Europe Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 50: Europe Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 51: Europe Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 52: Europe Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 53: Europe Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 54: Europe Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 55: Europe Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 56: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 57: Asia Pacific Biological Imaging Reagents Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 58: Asia Pacific Biological Imaging Reagents Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 59: Asia Pacific Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 60: Asia Pacific Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 61: Asia Pacific Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 62: Asia Pacific Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 63: Asia Pacific Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 64: Asia Pacific Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 65: Asia Pacific Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 66: Asia Pacific Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 67: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 68: Latin America Biological Imaging Reagents Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 69: Latin America Biological Imaging Reagents Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 70: Latin America Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 71: Latin America Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 72: Latin America Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 73: Latin America Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 74: Latin America Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 75: Latin America Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 76: Latin America Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 77: Latin America Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 78: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 79: Middle East & Africa Biological Imaging Reagents Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 80: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 81: Middle East & Africa Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 82: Mid

List of Figures

Figure 01: Global Biological Imaging Reagents Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 02: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Global Biological Imaging Reagents Market Value Share, by Class (2018)

Figure 04: Global Biological Imaging Reagents Market Value Share, by Modality (2018)

Figure 05: Global Biological Imaging Reagents Market Value Share, by Application (2018)

Figure 06: Global Biological Imaging Reagents Market Value Share, by End-user (2018)

Figure 07: Global Biological Imaging Reagents Market Value Share, by Region (2018)

Figure 08: Global Biological Imaging Reagents Market Value Share Analysis, by Class, 2018 and 2027

Figure 09: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contrast Reagents, 2017–2027

Figure 10: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Optical Reagents, 2017–2027

Figure 11: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nuclear Reagents, 2017–2027

Figure 12: Global Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 13: Global Biological Imaging Reagents Market Value Share Analysis, by Modality, 2018 and 2027

Figure 14: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by MRI, 2017–2027

Figure 15: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ultrasound, 2017–2027

Figure 16: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by X-ray & CT, 2017–2027

Figure 17: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Nuclear, 2017–2027

Figure 18: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Optical Imaging, 2017–2027

Figure 19: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 20: Global Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 21: Global Biological Imaging Reagents Market Value Share Analysis, by Application, 2018 and 2027

Figure 22: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vitro, 2017–2027

Figure 23: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vivo, 2017–2027

Figure 24: Global Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 25: Global Biological Imaging Reagents Market Value Share Analysis, by End-user, 2018 and 2027

Figure 26: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027

Figure 27: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Imaging Centers, 2017–2027

Figure 28: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Life Sciences Companies, 2017–2027

Figure 29: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Research Institutes, 2017–2027

Figure 30: Global Biological Imaging Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 31: Global Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 32: Global Biological Imaging Reagents Market Value Share, by Region, 2018 and 2027

Figure 33: Global Biological Imaging Reagents Market Attractiveness, by Region, 2019–2027

Figure 34: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 35: North America Biological Imaging Reagents Market Value Share, by Country, 2018 and 2027

Figure 36: North America Biological Imaging Reagents Market Attractiveness, by Country, 2019–2027

Figure 37: North America Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 38: North America Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 39: North America Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 40: North America Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 41: North America Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 42: North America Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 43: North America Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 44: North America Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 45: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 46: Europe Biological Imaging Reagents Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 47: Europe Biological Imaging Reagents Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 48: Europe Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 49: Europe Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 50: Europe Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 51: Europe Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 52: Europe Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 53: Europe Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 54: Europe Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 55: Europe Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 56: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 57: Asia Pacific Biological Imaging Reagents Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 58: Asia Pacific Biological Imaging Reagents Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 59: Asia Pacific Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 60: Asia Pacific Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 61: Asia Pacific Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 62: Asia Pacific Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 63: Asia Pacific Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 64: Asia Pacific Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 65: Asia Pacific Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 66: Asia Pacific Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 67: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 68: Latin America Biological Imaging Reagents Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 69: Latin America Biological Imaging Reagents Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 70: Latin America Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 71: Latin America Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 72: Latin America Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 73: Latin America Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 74: Latin America Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 75: Latin America Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 76: Latin America Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 77: Latin America Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 78: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 79: Middle East & Africa Biological Imaging Reagents Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 80: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 81: Middle East & Africa Biological Imaging Reagents Market Value Share, by Class, 2018 and 2027

Figure 82: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 83: Middle East & Africa Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 84: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 85: Middle East & Africa Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 86: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 87: Middle East & Africa Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 88: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 89: Market Position/Ranking Analysis, 2018, by Tier and Size of the Company

dle East & Africa Biological Imaging Reagents Market Attractiveness, by Class, 2019–2027

Figure 83: Middle East & Africa Biological Imaging Reagents Market Value Share, by Modality, 2018 and 2027

Figure 84: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by Modality, 2019–2027

Figure 85: Middle East & Africa Biological Imaging Reagents Market Value Share, by Application, 2018 and 2027

Figure 86: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by Application, 2019–2027

Figure 87: Middle East & Africa Biological Imaging Reagents Market Value Share, by End-user, 2018 and 2027

Figure 88: Middle East & Africa Biological Imaging Reagents Market Attractiveness, by End-user, 2019–2027

Figure 89: Market Position/Ranking Analysis, 2018, by Tier and Size of the Company

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Biological Imaging Reagents Market